Red Hat has been on a tare recently, gaining over 50% YTD on behalf of strong partnerships and acquisition synergies. The company has successfully boosted revenues and upped its guidance in most recent quarters. Red Hat's new product deployment has boosted subscriptions. I believe the company will beat their earnings estimates on Monday, but guidance should be...
Thor Industries has been on a tare recently, gaining over 40% in the last 12 months. The company has been experiencing high demand for its products and has worked on developing new products and revamping its existing ones. However, I believe the company's higher expenses and new market penetration costs will limit Income and Margins throughout the next quarter....
The company's share price has been under severe pressure since the deal with Walgreens $WBA has fallen through and low pharmacy reimbursement rates. Rite Aid's organic growth remains impressive, posting double digit sales growth in 2016. Earnings should get a boost from aggressive cost cutting measures. I believe the company's share price is way oversold and...
KB Home has been gaining steadily with the recovery in the housing market since 2009. The industry as a whole is enjoying solid demand from a recovering economy and a limited inventory. KB Home has been enjoying a steady boost to its business from increased rentals. The company has put effort on increasing revenues per community and profits per unit, boosting...
US GDP will be released at 8:30 ET, in 40 minutes. I believe the USD will weaken as a result of a lackluster report. Short term EURUSD target for weakening USD and stronger European prospects.
The company's recent efforts to launch new product is boding well for sales growth. An emphasis on cost management and operational efficiency should boost profits and margins. I believe the company will beat earnings and raise guidance. I have a $5.50 PT for the post-earnings move with a 2 month time frame.
Teva Pharmaceuticals $TEVA has shed over 50% of its value following its $6.1B impairment charge and 75% dividend slash in its latest quarterly report. Pros: - The company continues to expect double digit sales growth from its recent Actavis acquisition from Allergan $AGN. - Teva expects over 1,500 new drugs to launch in 2017, with over 900 drugs still pending...
After several lackluster quarters on behalf of soft North American sales, the company's strategic efforts have regrew sales potential. Strong growth in Emerging Markets and its eCommerce platform - Nike.com, expected to top $2B in sales contribution, have boosted overall sales growth. I believe the company's strategic efforts will results in an easy earnings and...
The company is facing a tough market environment with changing dynamics and stiff competition. Unlike some of its peers, the company has not yet put enough effort into revamping its products. The company is putting efforts into reducing costs but that only goes so far to improve sales guidance. Going into earnings, I believe the company is fairly to slightly...
Adobe is a wonderful company with a great array of products and services. The company has been gaining traction with its cloud offerings allowing for the conversion of enterprise customers to Enterprise Term License Agreements (ETLAs), resulting in higher Creative Cloud adoption. However, with great power comes great responsibility, and Adobe's expenses have been...
After a slowdown in sales in 2016 the company's management has put forth an effort to revamp products with changing industry trends. The company, as of late 2016, has presented their plan to revamp existing products and launch new ones. Some in partnership with Microsoft. Even earlier in the year, the company showed progress with sales decline greatly slowing...
Long term TA supporting my opinion of Gold being bearish ahead of the interest rate increase cycle. November & December FOMC meeting will set the tone. Caution against Italy's referendum on December 4th - Likely to close short before hand and re-take ahead of the December FOMC meeting. Second probability with no rate increase and a dovish guidance will remain...
Republican nominee Donald Trump is bad for the Mexican Economy with his trade deals, mass deportations and "The Wall". Mexican currency has priced in the worst throughout 2016. With recent plunge in the polls and Wall Streets declaration he lost in both debates, USDMXN is a good R/R short. S/L put at recent highs, excluding USD strength. Profit set at the 10%...
Retail earnings are in full swing this upcoming week! Here is a TA based version of my expectations for the week. In previous quarters the strong USD and the slow down in Consumer Spending hit profits hard. With retail sales up throughout the quarter and consumer confidence at 2016 high, all around beats are expected. Driving retail market capitalization back...
Apple Inc. $AAPL reports earnings after the bell on Tuesday and things don't look so rosy. The July FOMC (Federal Open Market Committee) rate decision is on Wednesday, July 27th. Unless some concrete data comes up until the report, a 25bps interest rate hike or a strong indication of one in the upcoming meetings will send the S&P500 down in an initial...
A clear R/R favoring the downside for AAPL earnings on July 25th after the closing bell. Fundamentals are not painting a rosy picture either, with a lower ASP and macroeconomic headwinds. Pick your poison, either seem to paint a gnarly picture.
Q2 Earnings season is starting in Monday, July 11th with major financial institutions reporting. Financials are projected to do slightly better then the previous quarter and may offer good upside potential. From a fundamental standpoint, most financials are undervalued when taking into account future interest rates. If "Market Stabilization" occurs in Q2 or Q3,...
First TA publication confirming my bullish opinion based on fundamentals and market sentiment.